메뉴 건너뛰기




Volumn 15, Issue 4, 2001, Pages 683-685

Management of patients refractory to platelet transfusion

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HISTOCOMPATIBILITY ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIBODY; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; THROMBOPOIETIN;

EID: 0035065905     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402075     Document Type: Review
Times cited : (10)

References (18)
  • 5
    • 0024410461 scopus 로고
    • Platelet transfusion therapy for alloimmunized patients: Selective mismatching for HLA B12, an antigen with variable expression on platelets
    • (1989) Blood , vol.74 , pp. 1172-1176
    • Schiffer, C.A.1    O'Connell, B.2    Lee, E.J.3
  • 11
    • 2642611953 scopus 로고    scopus 로고
    • Leukocyte reduction and UV-B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusion
    • The TRAP Study Group
    • (1997) New Engl J Med , vol.337 , pp. 1861-1869
  • 12
    • 0033485568 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia
    • (1999) Blood , vol.94 , pp. 3694-3701
    • Archimbaud, E.1    Ottmann, O.G.2    Liu-Yan, J.A.3
  • 17
    • 0033135237 scopus 로고    scopus 로고
    • A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia
    • (1999) Blood , vol.93 , pp. 3124-3126
    • Sagmeister, M.1    Oec, L.2    Gmur, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.